Health Condition 1: W540- Bitten by dog Health Condition 2: W558- Contact with other mammals
Conditions
Interventions
Intervention1: 2% Lignocaine Medicated Pad: Dose 2% Lignocaine 5ml or the volume required to soak the pad and cover the wound
frequency - single application
twenty minutes before rabies immunoglobu
Sponsors
Indian Council of Medical Research
Eligibility
Inclusion criteria
Inclusion criteria: Adult Patients more than 18 years coming to the Preventive Clinic or Antirabies clinic with Category three animal bites in whom Rabies Immunoglobulin Equine Rabies immunoglobulin or Human Rabies Immunoglobulin is advised. Children between 12 and 18 years with Category three animal bites in whom Rabies Immunoglobulin Equine Rabies immunoglobulin Human Rabies Immunoglobulin is advised will also be recruited after completion of six months of data collection and after the first DSMB review
Exclusion criteria
Exclusion criteria: The exclusion criteria are those who are not giving consent, known allergy to Lignocaine, history of contact dermatitis, any contraindications to lignocaine and all mucosal exposures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in Pain score in the intervention and control arm measured by Visual Analog Scale and Sound Eye Motor ScaleTimepoint: Before Rabies Immunoglobulin (RIG) administration During RIG Administration After RIG administration | — |
Secondary
| Measure | Time frame |
|---|---|
| cost-effectivenessTimepoint: one point after the procedure;adverse eventsTimepoint: till 42 days;factors determining immune responseTimepoint: one point during analysis | — |
Countries
India
Contacts
Public ContactZinia Thajudeen Nujum
School of Public Health, Kerala University of Health Sciences
Outcome results
None listed